Anti-JC Virus Antibody Levels in Serum or Plasma Further Define Risk of Natalizumab-associated Progressive Multifocal Leukoencephalopathy
Plavina T, Subramanyam M, Bloomgren G, Richman S, Pace A, Lee S, Schlain B, Campagnolo D, Belachew S, Ticho B. (2014) Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy. Ann. Neurol. 76, 802-812.
View Publication